You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 6 Pre-clinical pharmacodynamic biomarker assays of immune modulation can translate to inform exploratory endpoints of target engagement in first-in-human clinical trial stages of drug discovery

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
6 Pre-clinical pharmacodynamic biomarker assays of immune modulation can translate to inform exploratory endpoints of target engagement in first-in-human clinical trial stages of drug discovery

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 202088011
Dec 20201605
Jan 20211202
Feb 20212407
Mar 20213805
Apr 20213408
May 20211508
Jun 2021009
Jul 2021009
Aug 2021008
Sep 20210010
Oct 202148023
Nov 202167020
Dec 20214807
Jan 20225609
Feb 20227407
Mar 20229008
Apr 2022134015
May 2022102013
Jun 2022128015
Jul 20228007
Aug 20228008
Sep 202212408
Oct 2022116014
Nov 2022130011
Dec 2022146012
Jan 202311903
Feb 2023156014
Mar 2023200014
Apr 202311006
May 202313408
Jun 2023116013
Jul 202312808
Aug 202313604
Sep 20236405
Oct 202398012
Nov 2023134014
Dec 202314009
Jan 20244801
Feb 20249607
Mar 202412205
Apr 2024142011
May 202412606
Jun 20248801
Jul 20248003
Aug 20244202
Sep 20246005
Oct 20247405
Nov 20247409
Dec 202494010
Jan 2025118013
Feb 20254807
Mar 2025006
Apr 2025006
May 2025008
Jun 2025007
Total43970481